Sulfate transport in chondrodysplasia

Annals of the New York Academy of Sciences

Volumn 785, Issue , 1996, Pages 131-136

  Hästbacka, Johanna ^a,f   Superti Furga, Andrea ^b   Wilcox, William R ^c,d   Rimoin, David L ^c,d   Cohn, Daniel H ^c,d   Lander, Eric S ^a,e  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

SULFATE;

CARTILAGE; CHONDRODYSPLASIA; CONFERENCE PAPER; EMBRYO DEVELOPMENT; GENE ISOLATION; HUMAN; METABOLISM; NONHUMAN; SKIN FIBROBLAST; SULFATION;

EID: 0029759936     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb56251.x     Document Type: Conference Paper

References (29)

1. LI, H., N. B. SCHWARTZ & B. M. VERTEL. 1993. cDNA cloning of chick cartilage chondroitin sulfate (aggrecan) core protein and identification of a stop codon in aggrecan gene associated with the chondrodystrophy, nanomelia. J. Biol. Chem. 268: 23504-23511.
2. WATANABE, I. I., et al. 1994. Mouse cartilage matrix deficiency (cmd) caused by 7 bp deletion in the aggrecan gene. Nature Genet. 7: 154-157.
3. SUGAHARA, K. & N. SCHWARTZ. 1979. Defect in 3′-phosphoadenosine 5′-phosphosulfate formation in brachymorphic mice. Proc. Natl. Acad. Sci. U.S.A. 76: 6615-6618.
4. NEUFELD, E. F. & J. MUENZER. 1995. The mucopolysaccharidoses. In The Metabolic and Molecular Basis of Inherited Disease, C. R. Scriver, et al., Eds.: 2645-2694. McGraw-Hill. New York.
5. p22.3: Mutations in chondrodysplasia punctata (CDPX) ans implications for warfarin embryopathy. Cell 81: 15-25.
6. HÄSTBACKA, J., et al. 1994. The diastrophic dysplasia gene encodes a novel sulfate transporter: Positional cloning by fine-structure linkage disequilibrium mapping. Cell 78: 1073-1087.
7. SUPERTI-FURGA, A. 1994. A defect in the metabolic activation of sulfate in a patient with achondrogenesis type IB. Amer. J. Hum. Genet. 55: 1137-1145.
8. WALKER, B. A., et al. 1972. Diastrophic dwarfism. Medicine 51(1): 41-59.
9. HÄSTBACKA, J., et al. 1992. Linkage disequilibrium mapping in isolated founder populations: Diastrophic dysplasia in Finland. Nature Genet. 2(3): 204-211.
10. SCHECK, M., J. PARKER & D. DAENTL. 1978. Hyaline cartilage changes in diastrophic dwarfism. Virchows Arch. Pathol. Anat. Histol. 378: 347-359.
11. SILLENCE, D. O., et al. 1987. Atelosteogenesis: Evidence for heterogeneity. Pediatr. Radiol. 17(2): 112-118.
12. STERN, H. J., et al. 1990. Atelosteogenesis type III: A distinct skeletal dysplasia with features overlapping atelosteogenesis and oto-palato-digital syndrome type II. Amer. J. Med. Genet. 36(2): 183-195.
13. QURESHI, F., et al. 1994. Diastrophic dysplasia and atelosteogenesis II: Different manifestations of a common chondrodysplasia. Proc. ASHG 45th Annu. Meet. Montreal (also in Amer. J. Hum. Genet.).
14. SCHRANDER-STUMPEL, C., et al. 1994. De la Chapelle dysplasia (ateleosteogenesis type II): Case report and review of the literature. Clin. Dysmorphol. 3(4): 318-327.
15. QURESHI, F., et al. 1995. Histopathology of fetal diastrophic dysplasia. Amer. J. Med. Genet. 56: 300-303.
16. BOROCHOWITZ, Z., et al. 1988. Achondrogenesis type I: Delineation of further heterogeneity and identification of two distinct subgroups. J. Pediatr. 112: 23-31.
17. SPRANGER, J., & P. MAROTEAUX. 1990. The lethal osteochondrodysplasias. Adv. Hum. Genet. 19(1): 1-103.
18. SUPERTI-FURGA, A., et al. 1992. Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulfate transporter gene. Nature Genet. 12: 100-102.
19. HÄSTBACKA, J., et al. 1996. Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate transporter gene (DTDST): Evidence for a phenotypic series involving three chondrodysplasias. Amer. J. Hum. Genet. 58: 255-262.
20. SPRANGER, J. 1987. Bone dysplasia "families." Pathol. Immunopathol. Res. 7: 76-80.
21. DE LA CHAPELLE, A., et al. 1972. Une rare dysplasie osseuse lethalede transmission recessive autosomique. Arch. Fr. Pediatr. 29: 759-770.
22. WHITLEY, C. B., et al. 1986. de la Chapelle dysplasia. Amer. J. Med. Genet. 25: 29-39.
23. VAN DER HARTEN, H., et al. 1988. Achondrogenesis-hypochondrogenesis: The spectrum of chondrogenesis imperfecta. Pediatr. Pathol. 8: 571-597.
24. FESHCHENKO, S. P., et al. 1989. Molecular heterogeneity of proteoglycan aggregates of human hyalin cartilage in normal conditions and in systemic bone dysplasia. Vopr. Med. Khim. 35(2): 24-33.
25. FESHCHENKO, S. P., et al. 1989. The absence of type II collagen and changes in proteoglycan structure of hyaline cartilage in a case of Langer-Saldino achondrogenesis. Hum. Genet. 82(1): 49-54.
26. PENNYPACKER, J. P., K. KIMATA & K. S. BROWN. 1980. Brachymorphic mice (bm/bm): A generalized biochemical defect expressed primarily in cartilage. Dev. Biol. 81: 280-287.
27. GRAY, M. L., et al. 1988. Mechanical and physicochemical determinants of the chondrocyte biosynthetic response. J. Orthop. Res. 6(6): 777-792.
28. URBAN, J. P., A. C. HALL & K. A. GEHL. 1993. Regulation of matrix synthesis rates by the ionic and osmotic environment of articular chondrocytes. J. Cell. Physiol. 154(2): 262-270.
29. HUMPHRIES, D. E., C. K. SILBERT & J. E. SILBERT. 1988. Sulphation by cultured cells. Biochem. J. 252: 305-308.